{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:32:52Z","timestamp":1725669172059},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Foshan Science and Technology Agency","award":["2320001006380"],"award-info":[{"award-number":["2320001006380"]}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2020A1515011461"],"award-info":[{"award-number":["2020A1515011461"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Plan Program of Guangzhou","award":["202201020511"],"award-info":[{"award-number":["202201020511"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-024-01572-y","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:02:13Z","timestamp":1725602533000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of early use of Carbapenems perioperatively for urolithiasis with ESBL-producing Escherichia coli"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhilin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donglong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huacai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Ali","family":"Karag\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chonghe","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongda","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"issue":"2","key":"1572_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1067\/mda.2003.7","volume":"49","author":"B Foxman","year":"2003","unstructured":"Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49(2):53\u201370.","journal-title":"Dis Mon"},{"issue":"10","key":"1572_CR2","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1017\/ice.2017.156","volume":"38","author":"J McDanel","year":"2017","unstructured":"McDanel J, Schweizer M, Crabb V, et al. Incidence of extended-spectrum \u03b2-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: a systematic literature review. Infect Control Hosp Epidemiol. 2017;38(10):1209\u201315.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1572_CR3","unstructured":"Sutherland JW, Parks JH, Coe FL. Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab. 1985;11:267-9."},{"issue":"1","key":"1572_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/bju.13828","volume":"120","author":"G Zeng","year":"2017","unstructured":"Zeng G, Mai Z, Xia S, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017;120(1):109\u201316.","journal-title":"BJU Int"},{"key":"1572_CR5","unstructured":"Mykhalko YO. Antimicrobial susceptibility patterns of escherichia coli in children and adults with urinary tract infections. Wiad Lek. 2018; 71:306-10."},{"issue":"4","key":"1572_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.17305\/bjbms.2018.3544","volume":"18","author":"K Karlovic","year":"2018","unstructured":"Karlovic K, Nikolic J, Arapovic J. Ceftriaxone treatment of complicated urinary tract infections as a risk factor for enterococcal re-infection and prolonged hospitalization: a 6-year retrospective study. Bosn J Basic Med Sci. 2018;18(4):361\u20136.","journal-title":"Bosn J Basic Med Sci"},{"issue":"3","key":"1572_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000439441","volume":"95","author":"J Medina-Polo","year":"2015","unstructured":"Medina-Polo J, Arr\u00e9bola-Pajares A, P\u00e9rez-Cadavid S, et al. Extended-spectrum beta-lactamase-producing Bacteria in a Urology Ward: epidemiology, risk factors and Antimicrobial susceptibility patterns. Urol Int. 2015;95(3):288\u201392.","journal-title":"Urol Int"},{"key":"1572_CR8","doi-asserted-by":"crossref","unstructured":"Paterson DL, Ko WC, Von Gottberg A, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis. 2004;39:31\u20137.","DOI":"10.1086\/420816"},{"issue":"2","key":"1572_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/cid\/cir793","volume":"54","author":"F Perez","year":"2012","unstructured":"Perez F, Bonomo RA. Can we really use ss-lactam\/ss-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum ss-lactamase-producing bacteria? Clin Infect Dis. 2012;54(2):175\u20137.","journal-title":"Clin Infect Dis"},{"issue":"s2","key":"1572_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2362.2008.02008.x","volume":"38","author":"FME Wagenlehner","year":"2008","unstructured":"Wagenlehner FME, Pilatz A, Naber KG, Weidner W. Therapeutic challenges of urosepsis. Eur J Clin Invest. 2008;38(s2):45\u20139.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"1572_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13054-017-1658-5","volume":"21","author":"EJ Finkelsztein","year":"2017","unstructured":"Finkelsztein EJ, Jones DS, Ma KC, et al. Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit. Crit Care. 2017;21(1):73.","journal-title":"Crit Care"},{"key":"1572_CR12","doi-asserted-by":"crossref","unstructured":"Franchini S, Duca A. qSOFA should replace SIRS as the screening tool for sepsis. Crit Care. 2016;20(1).","DOI":"10.1186\/s13054-016-1562-4"},{"key":"1572_CR13","doi-asserted-by":"crossref","unstructured":"Vincent J-L, Martin GS, Levy MM. qSOFA does not replace SIRS in the definition of sepsis. Crit Care. 2016;20(1).","DOI":"10.1186\/s13054-016-1389-z"},{"key":"1572_CR14","doi-asserted-by":"crossref","unstructured":"Seo YB, Lee J, Kim YK et al. Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli. BMC Infect Dis. 2017;17(1).","DOI":"10.1186\/s12879-017-2502-x"},{"key":"1572_CR15","doi-asserted-by":"crossref","unstructured":"Starzyk-\u0141uszcz K, Zielonka TM, Jakubik J, et al. Mortality Due to Nosocomial Infection with Klebsiella pneumoniae ESBL. Adv Exp Med Biol. 2017;1022:19-26.","DOI":"10.1007\/5584_2017_38"},{"issue":"2","key":"1572_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ajur.2016.03.001","volume":"3","author":"AO Rashid","year":"2016","unstructured":"Rashid AO, Fakhulddin SS. Risk factors for fever and sepsis after percutaneous nephrolithotomy. Asian J Urol. 2016;3(2):82\u20137.","journal-title":"Asian J Urol"},{"key":"1572_CR17","unstructured":"\u00c7elikbilek N1, G\u00f6zalan A, \u00d6zdem B, et al. Extended spectrum beta-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res. 2002;116:145-149."},{"issue":"3","key":"1572_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jinf.2007.04.007","volume":"55","author":"M Melzer","year":"2007","unstructured":"Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. Coli compared to non-ESBL producing E. Coli. J Infect. 2007;55(3):254\u20139.","journal-title":"J Infect"},{"issue":"7","key":"1572_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1086\/598244","volume":"30","author":"K Hussein","year":"2009","unstructured":"Hussein K, Sprecher H, Mashiach T, et al. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol. 2009;30(7):666\u201371.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"1572_CR20","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/jac\/dkv094","volume":"70","author":"ML Winkler","year":"2015","unstructured":"Winkler ML, Papp-Wallace KM, Bonomo RA. Activity of ceftazidime\/avibactam against isogenic strains of Escherichia coli containing KPC and SHV \u03b2-lactamases with single amino acid substitutions in the \u03a9-loop. J Antimicrob Chemother. 2015;70(8):2279\u201386.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1572_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jmii.2012.09.001","volume":"47","author":"YH Wu","year":"2014","unstructured":"Wu YH, Chen PL, Hung YP, Ko WC. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. J Microbiol Immunol Infect. 2014;47(3):197\u2013203.","journal-title":"J Microbiol Immunol Infect"},{"key":"1572_CR22","doi-asserted-by":"crossref","unstructured":"Tamma PD, Han JH, Rock C et al. Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin Tazobactam for Patients With Extended Spectrum \u03b2-Lactamase Bacteremia. Clin Infect Dis. 2015;60(9):1319-25.","DOI":"10.1093\/cid\/civ003"},{"key":"1572_CR23","doi-asserted-by":"crossref","unstructured":"Benanti GE, Brown ART, Shigle TL et al. Carbapenems versus Cefepime or Piperacillin-Tazobactam for the Empiric Treatment of Extended Spectrum\u03b2-lactamase Producing Escherichia coli Bacteremia in Patients with Hematologic Malignancy. Antimicrob Agents Chemother. 2019;63:1813-18.","DOI":"10.1128\/AAC.01813-18"},{"issue":"6","key":"1572_CR24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/bju.14484","volume":"123","author":"D Chen","year":"2018","unstructured":"Chen D, Jiang C, Liang X, et al. Early and rapid prediction of postoperative infections following percutaneous nephrolithotomy in patients with complex kidney stones. BJU Int. 2018;123(6):1041\u20137.","journal-title":"BJU Int"},{"issue":"4","key":"1572_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657\u201386.","journal-title":"Clin Microbiol Rev"},{"key":"1572_CR26","doi-asserted-by":"crossref","unstructured":"Marchaim D, Sunkara B, Lephart PR, et al. Extended-spectrum betalactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the erao flowered breakpoints and no confirmatory tests. Infect Control Hosp Epidemiol. 2012;33:853\u20135.","DOI":"10.1086\/666632"},{"issue":"4","key":"1572_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jinf.2011.02.009","volume":"62","author":"Y-H Chen","year":"2011","unstructured":"Chen Y-H, Hsueh P-R, Badal RE, et al. Antimicrobial susceptibility profiles of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect. 2011;62(4):280\u201391.","journal-title":"J Infect"},{"issue":"1","key":"1572_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.diagmicrobio.2012.05.024","volume":"74","author":"DJ Hoban","year":"2012","unstructured":"Hoban DJ, Lascols C, Nicolle LE, et al. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase\u2013producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009\u20132010. Diagn Microbiol Infect Dis. 2012;74(1):62\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"1572_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.7196\/SAMJ.2019.v109i6.14002","volume":"109","author":"GA Richards","year":"2019","unstructured":"Richards GA, Brink AJ, Feldman C. Rational use of the fluoroquinolones. S Afr Med J. 2019;109(6):378\u201381.","journal-title":"S Afr Med J"},{"issue":"3","key":"1572_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.23736\/S2724-6051.23.05169-8","volume":"75","author":"C De Nunzio","year":"2023","unstructured":"De Nunzio C, Nacchia A, Lombardo R, et al. Is EMA warning on quinolones and fluoroquinolones really assessed? An EudraVigilance database analysis. Minerva Urol Nephrol. 2023;75(3):374\u201380.","journal-title":"Minerva Urol Nephrol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01572-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-024-01572-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01572-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:02:53Z","timestamp":1725602573000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-024-01572-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1572"],"URL":"https:\/\/doi.org\/10.1186\/s12894-024-01572-y","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"6 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study met the ethical requirements by the Local Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University. The Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University has waived the need of informed consent for this study. All methods were performed following the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}